Welcome to our dedicated page for Aehr Test Sys SEC filings (Ticker: AEHR), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The Aehr Test Systems (NASDAQ: AEHR) SEC filings page on Stock Titan provides access to the company’s regulatory disclosures as filed with the U.S. Securities and Exchange Commission. As a California-based supplier of semiconductor test and burn-in systems, Aehr uses these filings to report on financial performance, corporate governance, equity compensation plans, and other material events.
Investors can review current reports on Form 8-K, where Aehr discloses items such as quarterly and annual financial results, amendments to equity incentive and employee stock purchase plans, and outcomes of shareholder votes at its annual meetings. For example, recent 8-K filings describe the approval of amendments to the 2023 Equity Incentive Plan and the Amended and Restated 2006 Employee Stock Purchase Plan, as well as the ratification of the company’s independent registered public accounting firm.
The company’s proxy statement on Schedule DEF 14A provides detail on director elections, executive compensation proposals, advisory votes on pay and pay frequency, and the matters submitted to shareholders at the annual meeting. These documents help investors understand Aehr’s board structure, compensation programs, and shareholder voting results.
On Stock Titan, Aehr’s filings are updated in near real time from EDGAR. Users can access 8-Ks for earnings announcements and other material events, proxy materials for governance and compensation information, and related exhibits referenced in those filings. AI-powered summaries highlight key points, allowing readers to quickly see how developments in Aehr’s semiconductor test and burn-in business—spanning FOX wafer-level systems and Sonoma, Echo, and Tahoe package-level platforms—are reflected in its official disclosures.
AEHR Test Systems Executive VP of R&D Didier Wimmers completed an internal share purchase through the company’s employee stock purchase plan. On April 1, 2026, he acquired 1,873 shares of common stock at $6.6725 per share.
Following this transaction, Wimmers directly holds 16,059 shares of AEHR common stock, which includes shares tied to unvested restricted stock units. The purchase was made under the company’s tax-qualified Employee Stock Purchase Plan, which is treated as a tax-conditioned plan under Internal Revenue Code Section 423 and is exempt from certain short-swing trading liability rules.
Aehr Test Systems VP Alistair N. Sporck reported routine share movements involving compensation and employee purchase activity. On April 2, 298 shares of common stock at $44.32 per share were withheld to satisfy tax obligations upon vesting of restricted stock units, which the company states does not represent a sale. After this, he held 24,855 shares directly, including shares subject to unvested restricted stock units. On April 1, a separate 1,963-share transaction at $6.6725 per share, held indirectly by a trust, reflects shares purchased through the company’s employee stock purchase plan, which is described as a tax-conditioned plan exempt from certain Section 16 short-swing liability, with 7,177 shares held indirectly following that transaction.
AEHR Test Systems CFO Chris Siu reported routine equity-related transactions in company stock. On April 2, 821 shares of common stock at $44.32 per share were withheld to cover tax obligations upon vesting of restricted stock units, which the company notes is not a market sale. On April 1, 2,095 shares at $6.6725 per share were acquired through the company’s Employee Stock Purchase Plan and are held indirectly in a trust. Following these transactions, Siu holds 71,437 shares directly and 7,306 shares indirectly, with the indirect amount including shares subject to unvested restricted stock units.
AEHR TEST SYSTEMS executive Alberto Salamone reported routine equity compensation-related transactions. On April 2, 2026, 553 shares of common stock were withheld at $44.32 per share to cover tax obligations upon vesting of restricted stock units, which the disclosure states does not represent a sale by Salamone. On April 1, 2026, 1,672 shares of common stock were purchased through the company’s Amended and Restated 2006 Employee Stock Purchase Plan, described as a tax-conditioned plan under Internal Revenue Code Section 423. Following these transactions, Salamone directly held 78,025 shares of AEHR common stock, and this amount includes shares subject to unvested restricted stock units.
Aehr Test Systems executive Vernon Rogers reported routine equity compensation activity. On April 1, he acquired 1,558 shares of common stock at $6.6725 per share through the company’s Amended and Restated 2006 Employee Stock Purchase Plan, described as a tax-conditioned plan under Section 423 of the Internal Revenue Code and exempt from Section 16 short-swing rules.
On April 2, 336 shares of common stock valued at $44.32 per share were withheld to cover tax obligations when restricted stock units vested, which the disclosure clarifies is not a sale by Rogers. After these transactions, he directly holds 178,428 shares, and the reported amount includes shares underlying unvested restricted stock units.
Aehr Test Systems CTO Donald P. Richmond II reported routine equity compensation activity. On April 1, he acquired 2,120 shares of common stock at $6.6725 per share through the company’s Amended and Restated 2006 Employee Stock Purchase Plan, described as a tax-conditioned plan under Internal Revenue Code Section 423.
On April 2, 341 shares of common stock were withheld to satisfy tax obligations upon vesting of restricted stock units, which the company clarifies does not represent a sale by the reporting person. After these transactions, he directly owns 214,996 shares of common stock, and this amount includes shares subject to unvested restricted stock units.
AEHR Test Systems President and CEO Gayn Erickson reported routine share movements tied to equity compensation and tax obligations. On one date, 2,512 shares of common stock were withheld at $44.32 per share to cover tax liabilities upon vesting of restricted stock units, which a footnote clarifies does not represent a sale by him. A separate entry records 2,131 shares at $6.6725 per share as an “other” transaction, with a footnote noting certain shares were purchased through the company’s Amended and Restated 2006 Employee Stock Purchase Plan. Following these events, Erickson holds 250,918 shares directly and 291,628 shares indirectly through a trust.
AEHR TEST SYSTEMS Chief Operating Officer Adil Engineer reported routine equity compensation transactions. On April 1, 2026, he acquired 2,454 shares of common stock at $6.6725 per share through the company’s Amended and Restated 2006 Employee Stock Purchase Plan, described as a tax-conditioned plan under Internal Revenue Code Section 423.
On April 2, 2026, 458 shares of common stock valued at $44.32 per share were withheld to satisfy tax obligations upon vesting of restricted stock units, which the disclosure states does not represent a sale by the reporting person. After these transactions, Engineer directly owned 47,672 shares of common stock, and this amount includes shares subject to unvested restricted stock units.
The Vanguard GroupSchedule 13G reporting zero shares beneficially owned of Aehr Test Systems Common Stock as of 03/13/2026. The amendment explains an internal realignment effective 01/12/2026 that disaggregated certain subsidiaries and business divisions for reporting under SEC Release No. 34-39538.
The filing states Vanguard’s subsidiaries now report separately and that Vanguard no longer is deemed to have beneficial ownership of securities held by those entities.
Aehr Test Systems director Geoffrey Scott reported a charitable stock transfer. On a Form 4, he disclosed a bona fide gift of 5,104 shares of common stock to the Scott Family Fund. After the donation, he directly owns 52,864 shares and indirectly holds 60,686 shares through a trust and 140,000 shares through his spouse, with some amounts including unvested restricted stock units.